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Histological aspects of the Black African nephrotic syndrome: 42 cases
observed at Brazzaville University Hospital. C. Assambo-Kieli, J.
Kokolo, I. Mpio, A. Ngolet, CHU Brazzaville, BP 32, Republique du
Congo. We report the results of 42 kidney biopsies made in patients
suffering from nephrotic syndrome observed at Brazzaville University
Hospital. The observation period ran from January 1, 1986, to April 30,
1987, a total of 64 months. The group included 24 men and 18 women
aged from 12 to 64 years with an average age of 29 years. The optical
microscope histological examination of biopsy samples showed the
following lesions:
-18 glomerulonephritis (GN) with minimal glomerular lesions: 42.8%
-6 focal and segmental glomeruloscierosis (FSG): 14.2%
-6 endocapillary proliferative ON: 14.2%
-5 mesangiocapillary ON (MCGN): 11.9%
-2 membranous GN: 4.7%
-2 renal amyloidosis: 4.7%, 2 glomerulosclerosis (GS): 4.7%,
-1 nephroangiosclerosis (NAS): 2.3%
Our results reflect the diversity of histological lesions often noted
during the nephrotic syndrome with a predominance of minimal gb-
merular lesions. The average age of 29 years shows the known disease
predilection for the adolescent and the young adult. However, progno-
sis remains severe. Six patients died (14.6% of the cases) because of
end-stage renal failure. This gloomy prognosis reflects the complexity
of the lesions (3 MCGN, one FSG, one renal ainyloidosis and one
NAS), late diagnosis and inadequate treatment.
Angiodysplasia In hemodialyzed patients with chronic renal failure
(CRF): A frequent cause of anemia, treatment by Laser Nd YAG. L.
Aazib, P. Feydy, B. Coevoet, J. Brasseur, Z. Ghannoun, and E.
Driguez, Service Médecine, Unite Nephrologie and Unite gastro-
enterologie, C. H. G. St-Quentin 02100 (F) France. The gastrointestinal
bleeding of patients with CRF is an important factor of morbidity, and
can be responsible for severe anemia. It often has been related to
gastritis or gastroduodenal ulcer. Recently, anemia in hemodialyzed
patients was related to bleeding from gastroduodenal or colic angio-
dysplasia. The considerable frequency of this type of vascular abnor.
mality, its etiology and treatment remain to be specified. A population
of 102 hemodialyzed patients with CRF was followed in our Unit from
1/1/89 until 30/4/91; 32 had been explored by gastric or rectocolic
endoscopy either for gastrointestinal symptoms or severe or sudden
anemia or for pre-transplantation screening. Eleven patients (mean age
59 19) presented gastroduodenal angiodysplasia (8), gastroduodenal
and colic localization (2) or colic alone (1). When the cause of
exploration was gastrointestinal bleeding or sudden anemia (12 cases),
angiodysplasia was found in 8 (4 were bleeding during examination).
These 8 cases of angiodysplasia were treated by laser Nd YAG in one
or several episodes with no complications. Following this treatment no
need for transfusion was found and hemoglobin rate stabilized; these
parameters were assessed 3 months before and after laser was used.
Research for angiodysplastic abnormalities in patients with CRF is
difficult, however, it deserves special attention from nephrologists and
gastroenterologists during gastrointestinal screening. Significance of
these lesions in CRF patients remains to be discussed. The Nd YAG
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laser seems to be an efficient way to treat these hemorrhagic abnormal
ities.
What is the optimal dose of OKT3 as prophylaxis for rejection in renal
transplantation? D. Abramowicz, L. De Pauw, 0. Pradier, A. March-
ant, S. Florquin, J.M. Doutrelepont, P. Kinnaert, M. Goldman, and P.
Vereerstraeten, Nephrology and Immunology, Departments, Hopita4
Erasme, Bruxelles, Belgique. In our experience, prophylactic OKT3
therapy is associated with a significant increase in long-term kidney
graft survival. However, with conventional OKT3 protocol (5 mg/day
during 14 days) a substantial number of patients (14%) experienced
early acute rejection. In some of these patients (5/9), the reduction in
immunosuppression was associated with anti-OKT3 immunization. The
remaining patients displayed insufficient OKT3 serum levels at the
beginning of therapy (<500 nglml), in the absence of immunization.
These observations led us to assess the effects of increasing OKT3
dosage to 10 mg/day. We retrospectively compared a group of 66
patients treated from day I to day 14 with 5 mg/day OKT3 (gr.I) to a
group of 71 patients receiving 10 mg/day OKT3 (gr.II) during the same
period. Other immunosuppressive drugs (low dose steroids, azathio-
prine, and CsA) were identical in both groups. Patient survival at one
year (94% in gr.I vs. 98% in gr.lI) as well as total graft survival (82% in
gr.I vs. 81% in gr.II) were similar in the two groups. The intensity of
first dose reactions was not higher in gr.II patients. Rejection during the
14 days of OKT3 administration occurred in 3% of gr.II vs. 14% of gr.I
patients (P < 0.05). This reduced incidence of early rejection was
associated with higher OKT3 serum levels (mean SD on day 3: 1443
380 ng/ml in gr.II vs. 740 412 ng/ml in gr.I, P <0.001). At 3 months,
50% of gr.I vs. 71% of gr.II patients were free of rejection episodes (P
<0.05). Mean serum creatinine levels were similar at all time points.
The incidence of infections was marginally increased in gr.II, and one B
cell lymphoma was observed in that group in a patient who received a
second OKT3 course during the second post-transplant month. Six
patients from gr.II lost their grafts because of early thrombotic events
involving either glomerular capillaries or the renal vein. This could be
related to procoagulant effects of OKT3, as indicated by a massive
increase in serum prothrombin activation products 4 hours after the first
OKT3 dose. We conclude that increasing OKT3 dosage efficiently
presents early rejection episodes but favors the occurrence of intragraft
thromboses,
Detection of CR! mRNA and antigen Identifies the presence of imma-
tare podocytes In a case of Wilms' tumor (nephroblastoma). M-D. Appay,
M. Kazatchkine, D. Droz, P. Bobe, and J. Bariely, INSERM U 28,
HOpital Broussais, Paris, France. We studied a special case of Wilms'
tumor distinguished by numerous glomeruloid bodies. Using a specific
CR1 35S-labeled cDNA probe and anti-CR1 antibodies, CR1 mRNA and
CR! antigen-expressing cells were detected in glomeruloid bodies in
one case of Wilms' tumor. The concomitant expression of CR1 mRNA
and CR1 antigen, which characterizes podocytes in the immature renal
glomerular tuft in normal fetal kidneys (Appay M-D et a!, Kidney mt
38:289—293, 1990) indicates that glomeruloid bodies are composed of
immature podocytes.
CR! (C3b receptor) mRNA expression in podocytes of normal and
pathological glomeruli. In situ hybridization study. M-D. Appay, M.
Rouchon, C. Mandet, D. Nochy, M.D. Kazatchkine, and J. Bariéty,
INSERM U28, Hôpital Broussais, Paris, France. Using a specific CR1
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mRNA 33S-labeled cDNA probe and anti-CRI antibodies, we studied,
by in situ hybridization and immunoenzymatic techniques, the distri-
bution pattern of CR! mRNA and CR1 antigen in renal tissue specimens
of three normal subjects and in renal biopsies of 19 patients presenting
several nephropathies. CR! mRNA expression frequency was as fol-
lows:
normal human kidneys: 1/3
lupus glomerulonephritis: 6/6
membranoproliferative glomerulonephritis: 2/3
nephroangiosclerosis: 2/2
minimal change glomerulopathy 2/2
membranous g!omerulonephritis: 1/1
toxemia of pregnancy: 1/1
mye!oma: 1/1
IgA glomerulonephritis: 0/1
acute glomerulonephritis: 0/1
CR! antigen was detected in podocytes of all renal tissue specimens.
These results suggest that in normal conditions, CR! mRNA expression
varies and is not always detected in normal human kidney. On the other
hand, in some diseases such as lupus glomerulonephritis, CR1 mRNA
synthesis reaches sufficient amounts to be detectable in every case.
Thrombotic microangiopathy: Retrospective study of 34 adult cases. C.
Arvieux, C. Charasse, J. Rivalan, J. Gary, S. Gie, P. Lepogamp, P.
Simon, G. Guivarch, C. Camus, and M.P. Ramée, Néphrologie et
Hémodialyse, Reanimation medicate, Anatomie Pathologique, CHR
Pontchaillou, 35033 Rennes Cedex, Nephrologie, Reanimation médi-
cale, Centre Hospitalier La Beauchée, 22023 Saint Brieuc Cedex,
France. A retrospective study was done in 34 cases of thrombotic
microangiopathy (TM) defined by histological criteria (renal biopsy
performed in 30 cases) and/or on the presence of hemolytic anemia of
the microangiopathic type (mean age 40.8 18.4, range 0.17 to 80
years; sex ratio 0.23). The duration of follow-up was 36 55 months
(range 0.16 to 240 months). Clinical and biological data on admission
were: mean arterial pressure (MAP) 121 25 mm Hg; anuria 50%,
proteinuria 100%, hematuria 54%, serum creatinine level 638 573
smol/l, calculated GFR 22.6 22.5mI/mn, hemoglobin level 7 2 g/dl,
hemolysis 90%, elevated schistocyte count 83%, platelet count 109 94
109/liter, leucocyte count 13.2 10.4 106/liter. Initial treatment was:
hypotensives 50%, dialysis 68%, mechanical ventilation 21%; antiplate-
let agents 59%, steroids 23%, isolated plasma infusion 9%, plasma
exchange (PE) 44% (on average 10 procedures during 20 days). Results
were: Two etiological groups are defined: TM following mitomycin C
therapy (M): 6/34 cases; TM of other known or unknown origin (0):
28/34 cases, including four Post-partum cases. (1) No patients in the
group M experienced anuria or required dialysis during the follow-up;
one patient presented hypertension; one patient received PB; 4/6 died
from complications of their malignant neoplasia. (2) 14/28 patients in
group 0 underwent PE; age, incidence of previous hypertension, MAP,
creatinine serum level, hemoglobin level, leucocytosis, incidence of
anuria and dialysis requirement on admission, renal histological data
and duration of the follow-up were not significantly different. In the
group with PB the number of deaths was 1/14, in the group without PE
5/14, and the creatinine serum level at the end of follow-up (40 59
months) was significantly lower (P < 0.05). The duration of hematolog-
ical abnormalities and of anuria, and the number of patients requiring
later renal replacement therapy (RRT) are not different, Three patients
were dependent on PE. In both groups, with and without PE, hyper-
tension at the end of follow-up was severe (mean arterial pressure 105
18 mm Hg). Among the surviving patients, five immediately required
definitive RRT and two patients secondarily required RRT. (3)
Anatomo-clinical correlations were: involvement of arterioles and small
arteries was associated to higher MAP levels on admission; the calcu-
lated GFR on the admission was lower in the presence of interstitial cell
infiltrate (P < 0.05); later hypertension was more frequent if more than
50% of interstitial fibrosis was present. No relationships between
histological and clinical data were found in this retrospective study.
The value of renal biopsy in diabetes mellitus (D) with nephropathy (N).
D. Bennjs, D. Kleinknec/i,t, C. Gotheil, P. Ca/lard, F. Ma!, and J.J.
Altman, Centres Hospita!iers Pasteur-Vallery-Radot, Paris, Montreuil-
sous-Bois, and Jean Verdier, Bondv. France. We evaluated the value of
renal biopsy in 53 diabetic patients (pts) with N, 30 male and 23 female,
mean age 51.5 years (range: 27 to 77), followed for 12.7 years (range: 0.1
to 35). Eighteen pts with type I and 35 with type II-D underwent
systematic renal biopsy either percutaneously or via transjugular route.
Forty-nine pts were macroproteinuric, and 20 had proliferative retinop-
athy. Mean creatinine clearance was 50.4 mllmin (range: 5 to 161).
Glycemic control was tight in 17, fair in 25, and poor in II pts. On renal
biopsy specimens, 34 pts had isolated glomeruloselerosis (US), either
nodular (18) or diffuse (16). US, isolated or not, was more frequently
observed in type I-D (15/18 pts) than in type I1-D (24/35 pts), and could
occur in the absence of retinopathy (10), impaired GFR (3) and systemic
hypertension (2 cases). Another superimposed or isolated N, including
focal glomerulonephritis (GN), IgA-GN and membranous GN, was
more frequently found in pts with type 11(40%) than in those with type
1-D (27.7%). The presence of non-DN could not be predicted by the
absence of D retinopathy, the length of duration, or the quality of D
control. These results suggest that in D-pts: (1) rena! biopsy can be
safely performed by an endovenous route if the percutaneous technique
is contraindicated; (2) renal biopsy may disclose unexpected types of
non-DN, especially in type H-D pts, and this may have important
prognostic and therapeutic implications.
Progression of hyperhomocysteinemia in patients with chronic renal
failure (CRF). P. Chauveau, B. Chadefaux, M. Coudé, J. Aupetit, T.
Hannedouche. P. Kamoun, and P. Jungers, Departments of Nephrol-
ogy and Biochemistry, Necker Hospital, and Centre Edouard-Rist,
Paris, France. As moderate hyperhomocysteinemia is associated with
premature occlusive arterial disease, we prospectively determined
fasting plasma levels of total homocysteine (HCy) in 79 non-dialyzed
CRF pts (47 male) none receiving folate supplementation, and in 37 pts
(29 male) on maintenance hemodialysis (HD) for at least one year with
high-flux membrane, before and after a 4-hour dialysis session. Non-
dialyzed CRF pts were divided into 3 groups according to creatinine
clearance mI/mm): gr.I (>30, mild CRF); gr.II (10—30, moderate
CRF); gr.III (<10, advanced CRF). Mean (± so) values for HCy
concentrations in CRF and HD groups are shown in the table.
Groups
I
(N = 28) (N
H
= 29)
III(N = 22)
HD
(N = 37)
Ccr mI/mm 45.0 11.9 17.3 4.9 6.3 2.1
Age years 59.2 14.8 57.8 14.2 63.6 13.1 40.3 19.8
HCy pinol/liter 16.2 8.1 23.3 14.7 29.5 14.4 22.9 9.4
HCy level was significantly higher in CRF gr.I pts than in 45 healthy
controls whose mean HCy was 8.2 2.0 mol/l (P < 0.01), with a
further increase in groups II and III. Linear regression analysis showed
a significant negative relative between Ccr and HCy (r = 0.36, P <0.01).
Predialysis HCy level was similar to that observed in CRF gr.II pts, and
postdialysis level (11.3 5.3 z1mol/liter) remained higher than in
controls. Among 37 male CRF patients aged  50 years, HCy level was
significantly higher (28.9 16.3 vs. 17.8 8.9 .tmol/liter, P < 0.01) in
15 pts who had had occlusive arterial manifestations than in 22 who had
not. We conclude that HCy is increased from the early stage of CRF,
with a subsequent rise in parallel with the progression of CRF and only
partial correction by HD. Such hyperhomocysteinemia may constitute
a risk factor of premature arteriosclerosis in uremic patients.
Is chronic hepatitis B virus (HBV) infection frequent in adult patients
with glomerular disease in France? A study from 2 Departments of
Nephrology (Paris, Necker Hospital and Saint-Brieuc). N. Chen, P.
Lesavre, L.H. Noel, B. Mattlinger, P. Simon, M.C. Menault, M.P.
Ramée, M. Levy, Service de Nephrologie ef U.90 Inserm et Transfu-
sion sanguine, Hôpital Necker, Paris; Service de Nephrologie et
Transfusion sanguine, Saint-B rieuc; Laboratoire d'anatomie pat holog-
ique, Hopita! Pontchail!ou, Rennes; U.155 Inserm, Paris, France.
After the first report in 1971 of an adult patient in whom a nephrotic
syndrome occurred one year after a blood transfusion, a large number
of glomerulonephritic patients with chronic HBV infection were re-
ported. Most reports, however, concerned children, the glomerular
lesions encountered were usually membranous nephropathy (MN), and
most series concerned natients from Southeast Asia. To assess the
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frequency of HBV infection in patients with glomerular disease in
France, a low endemic country, we reviewed the series of patients
biopsied in the years 1983 to 1989 in two Departments of Nephrology.
In both Departments, all patients had been systematically investigated
for HBV markers before kidney biopsy. In Necker Hospital, HBs
antigen was detected in 2 of 75 patients with MN. The first one, of
Malian origin, was a healthy carrier with anti-HBc and anti-HBe
antibodies. The second, a Cambodian refugee, presented with chronic
active hepatitis. Serum contained HBV DNA and HBe antigen. HBs
antigen was also detected in one of the 32 patients showing a nephrotic
syndrome with minimal glomerular changes (MGC). This patient was a
healthy carrier coming from Burkina Faso. HBs antigen had not been
detected in any of the 15 patients with membranoproliferative glomer-
ulonephritis or in any of the 87 patients with igA nephropathy (IgAN).
Moreover, none of the 60 control patients (Alport syndrome, normal
kidney, chronic interstitial nephritis) was an HBs antigen carrier.
However, 25/209 patients showing a glomerular disease and 8/60 in the
control group had anti-HBs and/or anti-HBc antibodies. HBs antigen
was not demonstrated in any of the 86 patients in the Saint-Brieuc
Hospital (7 with MGC, 6 with focal hyalinosis, 30 with MN, and 43 with
IgAN). Three patients showed anti-HBc antibodies. The absence of
positive cases for HBs antigen in Saint-Brieuc may be explained by the
characteristics of the population, who are almost exclusively Caucasian
with nearly no immigrants. By contrast, in Paris a large number of
patients are immigrants coming from highly (Africa or Southeast Asia)
or intermediately (Mediterranean area, North Africa and Middle East)
endemic regions. In conclusion, in France as well as in North America,
very few patients with glomerulonephritis are chronic HBV carriers.
HBV infection seems, therefore, to play a minor role in the etiology of
glomerulonephritis. Nonetheless, because of the late severity of chronic
HB infection, routine HBV screening remains essential in patients
coming from prevalent areas or belonging to the high risk groups.
A comparative hemodynamic study of bicarbonate dialysis (BD) vs.
acetate free biofiltration (AFB) in patients (pts) prone to pre-dialytic
hypotension (hTA). C. Combe, J. Constans, C. Attoyan, A. Groussin,
V. de Précigout, L. Potaux, and M. Aparicio, Service de Nephrologie-
Hémodialyse. Hôpital Pellegrin, Bordeaux, France. AFB is a hemodi-
afiltration technique performed with a base-free dialysate and simulta-
neous infusion of isotonic bicarbonate solution. Other authors have
reported better hemodynamic tolerance of AFB vs. BD, which may be
due to the total suppression of Ac during AFB, or to the hemofiltration
part of AFB, although the volume of the perfused bicarbonate solution
is low, less than 101 per AFB session. The hemodynamic profile during
HD was studied in 8 pts selected for their hemodynamic instability
during HD (at least 2 symptomatic hypotensive episodes in the last 5
HD sessions). Each type of HD (BD and AFB) was performed twice for
each patient in a randomized order (total: 32 HD sessions). The number
of symptomatic hypotensive episodes was identical with the two
techniques (0.6 0.7 per session). The hemodynamic study was
performed with a computerized thoracic electrical bioimpedance mon-
itor. The results were analyzed by the analysis of variance for repeated
measures. Mean arterial pressure, systemic vascular resistance index,
cardiac index and stroke index decreased significantly with time during
HD, but no difference was detected between AFB and BD. On the
contrary, the decrease of ejection fraction (EF) with time was lower
during the AFB than the BD sessions (P < 0.005). It was compensated
for by a higher heart rate (HR) during BD compared to AFB (P <
0.001). Weight loss, type of dialyzer, conductivity (corrected for the
absence of base in the dialysate in AFB) and blood pump rate were not
different between the two techniques and cannot explain the observed
variations. These results suggest that the low Ac concentration in the
dialysate in BD does not induce significant vasodilation, compared to
AFB. The better hemodynamic tolerance of AFB vs. BD reported by
others could be explained by conservation of EF and stability of HR
during AFB. The continuous perfusion of isotonic bicarbonate, a!-
though performed at a rather low rate (1.65 0.07 liter/hr), can avoid
perdialytic hypovolemia, and therefore tachycardia and lowering of EF,
The decrease in EF and increase in HR observed in BD compared to
AFB may be due to the putative myocardial depressant effect of Ac.
The better correction of metabolic acidosis during AFB can also
contribute to the favorable myocardial effects of AFB. In conclusion,
the better hemodynamic tolerance of AFB vs. BD is due to a smaller
diminution of EF which does not require tachycardia to maintain a
stable cardiac output. The absence of Ac in the dialysate in AFB can
explain its beneficial effects.
Increased plasma levels of the soluble low-afilnlty receptor for IgE
(FcRIIICD23) associated with end-stage renal disease and exacerbated by
hemodialysis. B. Descamps-Latscha, A. Herbelin, A.T. Nguyen, D. de
Groote, and J. Zingraff, INSERM U 25 and INSERM U 90 Hdpital
Necker, Paris, France; Research Group Medgenix, Fleurus Belgium.
Patients with end-stage renal disease undergoing intermittent hemodi-
alysis (HD) show depressed cell-mediated immunity associated with
both phenotypic and functional signs of T cell activation. We recently
found elevated plasma levels of circulating IL-l, TNFa and IL-2
suggestive of monocyte activation, Abnormal antibody responses to T
cell-dependent antigens as well as IgE-mediated hypersensitivity reac-
tions have also been reported, but whether or not B cells are activated
in this setting is still controversial. Interestingly, non-dialyzed uremic
patients (IJR) also present evidence of both T cell and monocyte
activation. We now report on the possible role of a novel multifunc-
tional receptor/cytokine, soluble CD23 (FçRII), in the immune cell
activation associated with uremia and hemodialysis. Plasma levels of
sCD23 were measured before and after dialysis using a monoclonal
antibody-based immunoradiometric assay in 117 patients, including 95
HD and 22 UR patients, as well as in 31 healthy individuals. Before
dialysis, sCD23 levels were significantly higher in the UR patients than
in the healthy subjects (P < 0.001) and were strongly increased in the
HD patients (P < 0.0001 vs. UR patients). sCD23 levels were more
strongly elevated in both UR and HD patients with glomerulonephritis
or interstitial nephritis than in those with polycystic kidney disease (P
<0.01). Hemodialysis markedly influenced sCD23 levels as evidenced
by a significant increase at the end of the session in HD patients (P <
0.001), but not in the UR patients undergoing their first dialysis session,
together with significantly higher levels in HD patients dialyzed for six
months or more (P < 0.001). In addition, the increase was higher in the
patients dialyzed with cellulose than in those dialyzed with polyacriloni-
true membranes (P < 0.001). sCD23 levels were not associated with
increased levels of IgE but were correlated with IgG (P < 0.01) and 1gM(P < 0.05) levels. There was a concomitant increase in CD2S (sIL-2R)
levels; IL-4 remained undetectable. We therefore propose that: (1)
sCD23 may reflect B cell activation and that it may be involved in the
T cell activation associated with uremia; and (2) sCD23 may prove
useful as a novel marker of dialysis membrane biocompatibility.
Renal disease in HIV-1 infection. P. Dosquet, M. Delahousse, S.
Kenouch, D. Nochy, and J.Ph. Méry, Department of Nephrology,
Hôpital Bichat, and Department of Pathology, Hôpital Broussais,
Paris, France. Between August 1987 and April 1991, renal histology (19
biopsies, 2 autopsies) was obtained in a Parisian hospital in 21 pts with
HIV-1 infection (13 Blacks, 8 Whites; 17 males, 4 females; mean age
38.2 9.4 years). Five pts were asymptomatic HIV carriers, 8 had ARC
and 8 had AIDS. There was a large spectrum of renal lesions with the
predominance of glomerulonephritis (GN) (N = 14). There were 2 cases
of thrombotic microangiopathy, acute tubular necrosis and interstitial
nephritis each, and 1 case was diagnosed as "end-stage kidney."
Among ON, there were 5 cases of focal and segmental glomeruloscle-
rosis (FSGS) all in Black pts, 8 cases of immune-type ON (6 White, 2
Black pts) with mesangial and/or parietal deposits of IgO (N 7), IgA(N = 5), 1gM (N = 5), C3 (N = 8) and Clq (N = 3). Glomerular and
arteriolar AA amyloidosis was observed in the last pt. Diffuse intersti-
tial inflammatory infiltrates were observed in most cases of immune-
type GN. In 2 cases, monoclonal antibodies showed they were predom-
inantly made of CD8 lymphocytes. Conclusions: (1) As already
described, glomerular lesions may be observed in all stages of HIV-l
infection, and FSGS is observed mostly in Black pts; (2) immune type
GN is frequent in White pts; (3) interstitial infiltrates are most fre-
quently associated with immune-type ON, especially in ARC pts; like
those observed in other organs in HIV infection, they are made of CD8
lymphocytes.
Calcium mass balance during hemodialysis with standard-calcium
dialysate and low-calcium dialysate. G. Fournier, M. Corvazier, A.M.
PallueI, M. Yanal, and N.K. Man, A.I.R.B.P. Chartres and Départe-
,nent de Nephrologie, Hôpital Necker, Paris, France. To prevent
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inappropriate hypercalcemia due to administration of active vitamin D
and high dose of calcium carbonate, a tendency to decrease dialysate
calcium concentration (CaD) seems to be popular today. The purpose of
the study was to evaluate the effects of low-Ca dialysate on total and
ionized calcium changes in plasma and calcium mass balance during a 4
hr dialysis session, performed in 11 stable patients using sequentially
standard-CaD (1.625 to 1.75 mmol/Iiter) and low-CaD (1.0 to 1.25
mmol/liter). Ultrafiltrate volume was 3.7 0.3 and 3.6 0.3 liter,
respectively. CaD outlet, total Ca (t-Ca) and ionized Ca (i-Ca) in plasma
were determined every hour of the dialysis session by standard meth-
ods. Total Ca mass balance and fractional Ca shift from EC compart-
ment (ECC) and that from IC compartment (ICC) were evaluated.
There were no significant differences in t-Ca and i-Ca at pre-HD
between standard-CaD (2.43 0.04 mmol/Iiter and 1.09 0.03 mmol/
liter) and low-CaD (2.46 0.04 mmol/liter and 1.10 0.01 mmol/liter).
On the contrary, t-Ca and i-Ca at post-HD in standard-CaD (2.87 0.04
mmol/liter and 1.32 0.04 mmol/liter) were significantly higher than
those in low-CaD (2.53 0.04 and 1.12 0.02 mmol/liter, P < 0.005).
Accordingly, no significant difference was found in the t-Ca/i-Ca ratio
(0.45 0.01 vs. 0.45 0.01 at pre-HD and 0.46 0.01 vs. 0.44 0.01
at post-HD). As could be anticipated, dialysate calcium concentration
in the outlet at pre-HD was significantly higher in standard CaD (1.16
0.09 mmol/liter) than in low-CaD (1.40 0.03 mmol/liter, P <0.05), and
this significance was also seen at post-HD (1.63 0.08 mmol/liter vs.
1.39 0.03 mmol/liter, P < 0.05). In low-CaD, total Ca mass removal
during HD was 25.8 2.6 mmol/session where 8.0 0.7 mmoles are
coming from ECC and 17.8 2.5 mmoles from ICC. In standard-CaD,
only 2.1 3.5 mmoles were lost per dialysis session. Relative hyper-
calcemia was observed in standard-CaD, but post-HD i-Ca remained in
the normal range. Although no significant changes between the two
groups in body weight loss and blood pressure were seen, patients
treated with low-CaD experienced "washing syndrome," which could
be related to acute Ca depletion. It is concluded that with usual UF
volume, low-CaD could lead to negative Ca mass balance and subse-
quent complications in the long term. Concentration of calcium in
dialysate should be around 16.5 mmollliter to prevent, on one hand,
negative Ca mass balance and, on the other hand, inappropriate
hypercalcemia.
Comparative interest of interleukin-2 receptor, tumor necrosis factor
levels, and neopterine/creatinine ratio in the serum for monitoring renal
allogralts. J. Hacini, P. Berthoux, C. Guérin, E. Alamartine, M.
Vindimian, and F. Berthoux, Service de Nephrologie, Dialyse et
Transplantation Rénale, CHU St. Etienne; Hôpital Nord, Saint Priest
en Jarez; Service de Médecine Nucléaire, Faculté de Médecine, St.
Etienne, France. The serum level evolution of 3 cytokines, the ratio of
neopterine/creatinine (N/C), interleukin-2 receptor (IL2r) and tumor
necrosis factor (TNF), were prospectively studied in 55 kidney trans-
plant recipients. The 3 markers are secreted during T lymphocyte
activation. Their serum levels increased in acute rejection and infec-
tious disease. The patients were divided into 5 groups according to
clinical situation: stability (S), acute tubular necrosis (ATN), acute
rejection (R), bacterial or viral infection (I) and cyclosporine overdose
(CsA). The respective values are: in stability, N/C (124 29 x 106),
IL2r (128 62 pmol/liter), TNF (14 7 ng/Iiter); in ATN, N/C (123
41 x l0), IL2r (232 240 pmol/liter), TNF (14 0.4 ng/liter). A
significant rise of N/C ratio, (321 158 x 106), IL2r (402 207
pmol/liter) without significant rise of TNF (24 ng/liter), was observed
during acute rejection (P < 0.01). During infection episodes, the
elevation of the 3 markers, N/C (487 223 x 106), IL2r (778 870
pmol/liter) and TNF (60 80 ng/liter), is greater; P (< 0.01). In the CsA
cases, we noted a reduction of N/C ratio (60 22 x 10—6) and a lesser
reduction of IL2r (90 50 pmol/liter). The study of variables such as
sensitivity (Se), specificity (sp), positive predicative (vpp) and negative(vpn) value, shows that N/C ratio is the most interesting marker in
different situations. The study of combined utilization of 3 markers
shows that only TNF + N/C is interesting in infectious situations, with
99% sensitivity and 92% specificity.
Quantification and modulation of thrombomodulin activity in isolated
rat glomeruli. A. Kanfer, and C.J. He, Service de Néphrologie A and
INSERM U 64, Hôpital Tenon, Paris, France. Thrombomodulin (TM)
is the endothelial cell surface glycoprotein receptor for thrombin
formed during the clotting process. Once bound, thrombin loses its
coagulant activity and catalyzes activation of protein C which macti-
yates procoagulant factors V and VIII. TM and the protein C antico-
agulant system are involved in the maintenance of vascular nonthrom-
bogenicity, and depressed TM activity may be associated with
intravascular fibrin formation. TM antigen was previously found by
immunohistochemical methods in glomeruli (Lab Invest 54:172, 1986).
We report that TM-like activity is present in isolated detergent-
solubilized rat glomeruli. Glomerular extracts accelerated the spectro-
photometrically determined rate of hydrolysis of the chromogenic
substrate S2238 by activated protein C (APC) formed in presence of 10
nM thrombin; no APC was formed in the absence of thrombin and only
minimal amounts were formed in the absence of glomerular extracts.
The effects of the extracts were similar to those of commercial purified
TM. One mg glomerular protein generated 681 115 nmol APC, which
corresponded to the effect of 845 ng of purified TM. TM activity was
correlated with the protein content of glomerular extracts (r = 0.94).
Glomerular extracts prolonged rat plasma activated partial thrombo-
plastin time (APTT). Incubation of glomeruli with tumor necrosis
factor-a (TNF) and E. co/i lipopolysaccharide depressed hydrolytic
activity of glomerular extracts in a dose and time dependent manner, in
conformity with the known effects of both substances on TM activity of
other origins; incubation with TNF suppressed the effect of glomeruli
on APTT. In conclusion, glomeruli possess measurable TM activity; its
evaluation may contribute to elucidate the mechanisms of intraglomer-
ular fibrin deposition in various nephropathies.
Kinetics of technetium-labeled heparin in hemodialyzed patients. G.
Majda/ani, A. Kachko, J. Chomant, and N.K. Man, General Hospital-
Evreux, Henri Becquerel Medical Center-Rouen and Necker Hospital-
Paris, France. Several reports indicated that heparin in long-term
therapy could play a role in mineral metabolism resulting in bone
fracture and/or osteopenia. Technetium-labeled heparin kinetics studies
were undertaken in 12 hemodialyzed patients (P), where heparin was
used in long term (1 to 10 years) for anticoagulation of the extracorpo-
real circuit. The '°Tc-heparin (Solco Nuclear France) used, has a 10
mCi activity and a labeling efficiency of more than 95%. Two healthy
subjects served as control (C). After an i.v. bolus of 2 ml mTcheparin,
corresponding to 170 10 IU, radioactivity of kidney, liver, knee and
shoulder was recorded with a gamma camera at ti, t3 and t6 hrs for 120,
152 and 215 seconds, respectively. Scintigrams were computerized,
giving quantitative data for comparison. Results expressed in iO K
count (mean sEM) are given in the Table.
t Kidney Liver Knee Shoulder
ti-C 30.7 3.4 62.1 18.4 4.9 0.4 10.7 1.4
ti-P 13.1 0.6 66.2 5.7 11.3 1.1 17.3 1.1
t3-C 33.7 3.8 56.9 16.1 5.7 0.7 10.9 1.7
t3-P 11.5 0.6 63.5 6.3 13.4 1.1 19.9 1.0
t6-C 35.6 2.8 52.5 12.7 5.3 0.6 10.1 0.9
t6-P 11.8 0.3 64.5 6.4 14.7 0.8 20.8 1.1
Accumulation of radioactivity was significantly higher on knee (P <
0.05 at tl, P < 0.02 at t3, P < 0.001 at t6) and on shoulder (P < 0.05 at
tl, P < 0.01 at t3, P < 0.01 at t6) in patients than in control subjects on
the same areas. These data addressed the issue of hepann-induced
osteopenia in hemodialyzed patients, since heparin has direct inhibitory
effects on DNA and collagen synthesis.
Post-transplant monoclonal gammapathy. A. Modesto, L. Rostaing,
M. Abbal, D. Durand, and E. Ohayon, Laboratoire d'Immunologie,
Service de Néphrologie, CHU Rangueil, Toulouse, France. Post-
transplant lymphoproliferative disorders and viral infection are a well
recognized association. The spectrum ranges from benign monoclonal
or polyclonal B cell proliferation to malignant lymphoma. During a
two-year period, from 1989 to 1990, 137 renal, 30 heart and 23 liver
transplants were performed in our center. All received prophylactic
ALG during 8 days, followed by triple therapy with cyclosporine,
prednisone and azathioprine. Immunofixation follow-up, twice a
month, of these 190 transplant recipients revealed monoclonal gammap-
athies (MG) in 13 cases (6.8%). A single MG was found in 4 cases. Nine
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others presented double or triple monoclonal immunoglobulins, often
superimposed on an oligoclonal pattern. The overall distribution was: 5
IgG kappa, 6 LgG lambda, 41gM kappa or lambda MG, and no IgA MG.
The interval between transplantation and the appearance of MG varied
from 1 to 15 months (average, 5 months). Main features of these 13
patients were as follows: 11 men, 2 women; 4 renal, 4 liver, 4 heart, I
double renal-liver transplantation; average age at the time of transplan-
tation, 50 years (vs. average age in our transplant population: 41 years).
In 7 cases, ALG prophylactic therapy was pursued beyond the 8th day.
Eight cases received one or several antirejection treatments (steroids in
7 cases, steroids and ALG in the other), reinforced in 2 cases with
OKT3. In 11 cases, evidence of viral infection preceded the appearance
of MG: 9 CMV, 3 primary or reactivated EBV infections, and I
hepatitis B reactivation, In two cases, CMV and EBV infection were
associated. In one case, MG was detected one week after pneumocystis
pneumopathy. In 9 patients, without interruption of immunosuppres-
sion. MG disappeared within a period of I to 4 months, with a frequent
persistent oligoclonal pattern. In 3 patients follow-up of MG was less
than 4 months. In one case, MG persisted beyond 4 months. Four
patients died: 1 cardiac rejection with persistent CMV infection, 2 liver
transplant recipients with bacterial and fungal infection, I lymphoma.
In our series, MG usually occurs in transplanted patients over 50 years
old, after viral infection, with a prevalence of CMV over EBV infection.
It is often transitory, without myeloma, but might reveal over-immu-
nosuppression.
Unusual frequency of acute post-infectious glomerulonephritis (GN)
and renal insufficiency in patients with alcoholism, with or without
cirrhosis of the liver. J.J. Moniseny, D. Kleinknecht, A. Meyrier, P.
Ca/lard, and F. Mal, Hôpital Avicenne, Bobigny, Centre hospital/er,
Montreal!, and Hôpital Jean Verdier, Bondy, France. Between 1976
and 1991, we investigated 62 consecutive patients (pts) with acute
post-infectious GN, All presented with an acute nephritic and/or a
nephrotic syndrome, and had a percutaneous renal biopsy. Forty-eight
pts had acute renal failure with oligoanuria in 9. Seventeen (27%) of
these pts were alcoholics including 6 with cirrhosis of the liver. In
alcoholics renal histology, disclosed pure endocapillary GN in 8, endo-
and extracapillary GN in 6, and membranoproliferative GN in 3. Acute
or chronic tubulointerstitial lesions were found in 7 pts. Acute renal
failure was present in 15 pts and necessitated dialysis in 4/17 pts. The
microorganisms responsible for the GN were identified in 9/17 pts and
included Staph. aureus in 3, Strept. D in 2, Strept A., Strept. 0, Staph.
epidermidis, and Hemophilus influenza (I pt each). Staph. aureus and
Strept. were associated in 1 pt. The origin of the sepsis was the skin
(7/17 pts vs. 7/45 pts in non-alcoholics, P < 0.01), the teeth in 5 pts, the
lung in 3 pts, the oropharynx in 2 an infected ascites and/or osteoar-
thritis in 1 Pt. Blood cultures were positive in 4 including 2 pts with
endocarditis and 1 with endocarditis and a pulmonary metastatic
abscess. All received appropriate antibiotic therapy but 3 died from
sepsis. After a mean 15 months of follow-up, 5 pts had recovered full
renal function, but signs of chronic GN persisted in 7 and 1 had evolved
to end stage renal failure. Conclusion: (1) Acute post-infectious GN is
unusually frequent in alcoholics with or without cirrhosis of the liver
and often leads to death or chronic GN. (2) Predominant portals of entry
are skin and teeth. (3) Predisposing causes might be related to the
immunocompromised background of these pts, as documented by the
7-fold higher incidence of infection among cirrhotics.
Cellular toxicity of gentnmicin: A comparative study of the toxic
response of rabbit kidney proximal tubule cells in primary cultures and
the LLC-PK1 and OK cell lines. J.P. Morin, C. Monteil, B. Moulin, and
J.P. Fillastre, INSERM U-295, Universiré de Rouen, France. A pri-
mary culture is developed from calibrated fragments of highly purified
proximal tubules isolated from rabbit kidney. These cells are grown in
DMEM/HamFl2 medium fortified with sodium selenite, human trans-
ferrin and hydrocortisone, either (1G) without insulin or glucose
(moderate glycolysis and high brushborder activities) or (IG) with
insulin and glucose 5 m and insulin 5 g/ml (high glycolysis and low
brush border activities). LLC-PK1 and OK cells were grown in LG
medium without serum. Cultured cells were exposed for 72 hours to
gentamicin at the concentrations of 0.2 mrvt, I mat and 2.5 mM.
Intracellular activities of Na/K-ATPase (NAK), N-acetyl-3-D-glu-
cosaminidase (NAG), y-glutamyl transpeptidase ()QT), lactate dehy-
drogenase (LDH) and intracellular uptake of gentamicin were assessed
as relevant parameters for the evaluation of gentamicin induced cellular
alterations. The activity of NAK undergoes a dose dependent decrease
in IG primaries which does not occur in 1"G primaries or in
LLC-PK1 or OK cell lines. A significant increase in NAG activity is
seen in both primaries which is not seen in LLC-PK1 or in OK cell
lines. A dose dependent decrease in LDH activity was seen in both
primaries with a lower threshold in 1G than in LDH activity
remained unaltered in LLC-PK1 and in OK cell lines. Intracellular
uptake of gentamicin ranked as follows: OK < primaries IG <
LLC-PKI = Primaries 1-0-. This study clearly shows differences in
the toxic response pattern according to cell type and/or culture condi-
tions. Up to now, the model of primary culture of rabbit kidney
proximal tubule cells grown in the absence of insulin and glucose
exhibits the closest pattern of toxic response to gentamicin compared to
the in vivo situation in both the rat and the rabbit kidney.
Nature of AgHB5 in dialysis ultrafiltrate of chronic AgHBs carrier
hemodialyzed patients. A. Moynot, P. Dubreuil, C. Buisson, and J.
P1/lot, AURA H.K., Paris, and Hópiral Antoine-Béclére, Clamart,
France. In a previous study we demonstrated, by ELISA, AgHBs in
9/16 100-times concentrated ultrafiltrate samples (UF x 100) from
AgHB5 chronic carrier (AgHBs+) hemodialyzed patients (HD pts). The
quantities detected were low and varied, and were not correlated with
the sieving coefficients of the membranes (Mb) used or with circulating
AgHBs levels. To determine whether the AgHBs molecules were intact
(molecular wt = 2000 kDa) or degraded, the components of the virus B
envelope in the UF x 100 of our previous study were precipitated by
sheep antiserum to HBs, then polyethylene glycol, to select and
concentrate the AgHBs in the form of immune complexes. The precip-
itates obtained corresponded to a concentration of approximately 10
times the UF < 100. The various components were separated by
electrophoresis on acrylamide gel with and without reduction, then
transferred onto nitrocellulose and revealed with anti-HBs antibodies
recognizing sequential epitopes. By this method, AgHBs was found in
12/16 of the UF X 100 samples, only in macromolecular (Mm) form
since it does not penetrate into the gel, at a molecular wt > 120 kDa
(8/12 samples), or associated with traces of degraded AgHBs of low
molecular wt. This Mm form dissociates by reduction into polypeptides
of aberrant molecular wt compared to the known subunits of AgHB5
(24,28,31,33,39 and 41 kDa). Most polypeptides so detected have a
molecular wt of the order of 55-60 kDa, or of <24 kDa, which is the
smallest subunit of native AgHBs. No polypeptide found after dissoci-
ation of the Mm corresponded exactly to the subunits of native AgHBs.
Passage across the Mb may explain the denaturation of the AgHBs.
Whatever the explanation, the AgHB5 detected in AgHBs + HD pts is
undeniably altered but of high molecular weight (>120 kDa), whatever
the sieving coefficient of the Mb used.
Use of a placement site in patients on chronic hemodialysis. H. My, M.
Ga/let, G. Kepenekian, J. Cibert, J. Manchon, and M. Lopez, Hôpital
Saint-Joseph, Lyon, France. For vascular access in patients on chronic
hemodialysis, a silicone-made catheter (length = 25 cm; internal/
external diameter = 2/3,2 mm) was placed in 4 patients. The catheter is
provided with a titanium reservoir (thickness = 10.5mm; diameter = 32
mm). In 2 other patients, a double opening was made in the catheters,
using a double chamber formed by the soldering of 2 basal elements.
The upper surface of the reservoir (diameter = 13 mm) is made of
silicone, a material which permits multiple punctures. The tightness of
the reservoir remained perfect in experimental conditions up to 600
consecutive punctures, corresponding to 4 years of dialysis with 3
sessions per week. After the placement of the catheter in a deep vein,
the reservoir is placed in the subcutaneous tissue, in subclavicular
position. Puncture of the system requires a particular cannula with an
internal diameter of 1.6 mm, provided with a telescopic double man-
drin. A blood flow of 200 to 250 mllmin can be obtained. Technical
changes that are under way may enable the blood flow to reach 300
mI/mm in the near future. Today, the most significant observation time
that was reached amounts to 8 months. This technique demonstrates
very satisfactory clinical tolerance. No infectious problem has been
noted owing to the usual stringent surgical asepsy. Skin tolerance to
puncture wounds is perfect providing that the latter are regularly
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spaced. The pain due to the puncture is minor. There was no throm-
bosis of the site. The future of this technique seems promising as a
means of blood access in the mid-run and perhaps in the long run in
patients in whom arteriovenous fistula cannot be created or in patients
with heart failure who cannot undergo peritoneal dialysis. This tech-
nique may decrease the risk of infection as there are neither external
material nor permanent skin puncture wound. It also provides the
patient with a much appreciable comfort due to the absence of skin
dressing.
Anticardiolipin antibodies and intraglomerular thrombi in systemic
lupus erythematosus with renal involvement. B. Page, Z. Amoura, J.-P.
Viard, L.H. Noel, P. Lesavre, and J.-P. Grunfeld, Département de
Néphrologie, Hôpital Necker, Paris, France. Anticardiolipin antibod-
ies (ACAs) have been associated with arterial and venous thrombosis in
systemic lupus erythematosus (SLE). To investigate the relationship
between ACAs and intraglomerular thrombi, 24 SLE patients with renal
disease were studied (20 women and 4 men, aged 19 to 61, mean: 33.6
years). SLE was diagnosed according to the ARA criteria. All patients
had one renal biopsy. Renal disease was classified as diffuse prolifera-
tive glomerulonephritis (N = 14), membranous nephropathy (N = 2),
focal glomerulonephritis (N = 4), isolated mesangial deposits and
unclassified nephropathy (N = 3). IgG ACAs were determined by
ELISA. Sera were considered positive above 40 GPL units (mean of 50
normal sera plus 2 SD). Results are: sixteen of 24 patients (66%) had a
positive ACA test, Among these sixteen, 2 had recurrent arterial or
venous thrombosis and 3 had neurological symptoms. Among the
twelve women who became pregnant, the 4 who had experienced
spontaneous recurrent fetal loss had ACAs (mean: 151 GPL units).
Three patients had thrombocytopenia (2 ACA+, 2 ACA—). Three
patients had an antiprothrombinase lupus-type anticoagulant (mean:
350 GPL units). Eight of 24 patients (33%) had intraglomerular thrombi
(4 ACA+, 4 ACA—). Immunofluorescence on renal biopsy disclosed
fibrin deposits in 9 patients (4 ACA+, 5 ACA—), Among the 14 patients
with diffuse proliferative glomerulonephritis, 8 (group A) showed intra-
glomerular thrombi and 6 did not (group B). The mean activity index in
the 2 groups was similar (A: 8, B: 6). The percentage of patients with
ACAs was not significantly different in the 2 groups (A: 50%, B: 66%).
Conclusion: no correlation was found between ACA positivity and the
presence of intraglomerular thrombi in patients with SLE and renal
involvement.
Clotting of vascular access in dialysis patients associated to anticardio-
lipin antibodies. B. Page, J. Zingraff, and P. Bourquelot, Département
de Nephrologie, Hôpital Necker, and Service d' Urologie, HOpilaI
Saint-Joseph, Paris, France. Anticardiolipin antibodies (ACA5) have
been associated with arterial and venous thrombosis. In a small number
of dialysis patients vascular access remains a problem of major concern
because of repeated clotting of the fistula. We here report a series of 6
hemodialyzed patients, 4 men, 2 women, admitted for repair of ob-
structed A-V fistula. Their mean age was 46.3 years (range: 25.-69); two
patients were not yet on regular dialysis, one had been treated for 14
years and the others for 1,4 and 5 years, respectively. None had
autoimmune disease; systemic lupus erythematosus was ruled out in all
based on clinical history and the low titer of anti-DNA antibodies. The
search for ACAs was significantly positive in these patients, ranging
from 50 to 90 GPL units. IgG ACAs were determined by ELISA. The
result was considered to be positive for values >40 GPL units (2 SD
superior to the mean of controls). Routine clotting tests including
determination of protein C, protein S, and antithrombin III were normal
in all 6 patients. In 4 of the 6 patients antivitamin K therapy was
successful to guarantee the patency of vascular access. We conclude
that in dialysis with repeated clotting of A-V, fistula search for the
presence of ACAs should be done systematically.
Liddle syndrome: An unexpected cause of nephrocalcinosis (N) and
chronic renal failure (CRF). M. Nob/ins, D. K/einknecht, J.P. Dommer-
gues, C. Nazareth, andR. Garay, Department of Pediatrics, Hôpital de
Bicêtre, Department of Nephrology, Hôpital de Montreui/, and Forma-
tion INSERM Pharmacologie des Regulations Vasculaires, Hôpital
Necker, Paris, France. Liddle syndrome was diagnosed in 2 Black
sisters and 1 Caucasian girl, aged I to 5 years, who presented with
polyuria, polydipsia, growth retardation and hypertension. All had
hypokalemia, renal K wasting, metabolic alkalosis, and low levels of
plasma renin activity and plasma aldosterone. Two of 3 patients (pts)
had hypercalciuria (2.8 to 13 mg/kg/day). N was diagnosed in 2 pts on
renal echography or on CT-scan. Renal biopsy showed N in I and focal
interstitial fibrosis in 2 pts. Hypertension and hypokalemia were not
corrected by a low Na diet, spironolactone or dexamethasone. Serum K
levels were normalized by triamterene (10—15 mg/kg/day). Normal
blood pressure was only achieved with a combination of triamterene,
low Na diet, and acebutolol and/or clonidine. The 3 girls had a low
therapeutic compliance, and hypertension and hypokalemia remained
for prolonged periods. CRF was present in the 2 sisters at the age of 18
and 19 years, of whom I required hemodialysis; 3 years later, she
received a renal allograft. Hypertension and hypokalemia progressively
disappeared and she subsequently delivered a nonnal and normokale-
mic boy. Investigation of ion membrane fluxes in red blood cells
revealed that all patients had increased passive K fluxes (ground
membrane K leak) and an increased activity of the K-Cl cotransport
system. These results show that: (1) Liddle syndrome may be associ-
ated with hypercalciuria and/or N, and to CRF; (2) renal transplantation
can correct the clinical signs of the disease; and (3) the Liddle syndrome
is associated with an increased K turnover across cell membranes.
Erythropoietin treatment of anemia associated with end-stage renal
disease and multiple myeloma. P. Ruedin, P. Benedet, A. Péchère
Bertschi, and M. Leski, Division of Nephrology, University Hospital,
Geneva, Switzerland. Recombinant human erythropoietin (rHuEPO)
has been successfully used to correct anemia of chronic renal failure
and anemia of multiple myeloma (MM). Nevertheless, its efficacy and
tolerance are poorly documented in patients on chronic hemodialysis
(CHD) suffering from MM. We report our experience in treating anemia
with rHuEPO (Eprex®) in 3 males and I female on CHD for end-stage
renal disease secondary to advanced MM; the type of M component
was igG kappa in all cases. Mean age was 64.3 5.5 years (x so) (60
to 73) and duration of dialysis was 19.3 23.6 months (median 8.3).
Only 1 patient was still receiving chemotherapy when starting rHuEPO.
Before rHuEPO treatment, hematocrit (Ht) was 23.3 3% (19 to 26)
and during the 6 months preceding this therapy patients received a
mean quantity of packed red cell transfusions of 10.3 7.6 units/
patient. Following the first month of treatment (correction phase), Hct
was up to 32 4% with a mean dosage of rHuEPO of 180 38
lu/kg/week. Route of administration was intravenous in 2 cases and
subcutaneous in the other 2, thrice weekly. Duration of rHuEPO
treatment was 11.1 10.5 months (median 8.4) and 3 patients were still
undergoing therapy at the time of this study. Maintenance dose for the
last 3 months was 143 37 lU/kg/week and Hct was 35 1%. After
introduction of rHuEPO, no blood transfusions were required and
patients reported an improvement in well-being. We did not observe
any worsening of MM during rHuEPO treatment. Antihypertensive
therapy was started in I case and dosage was increased in 2 patients
during the course of rHuEPO therapy. In conclusion: (I) rHuEPO
treatment of anemia in patients with MM undergoing HD is justified in
order to improve well-being and to avoid the risks secondary to blood
transfusions. (2) In these cases, doses of rHuEPO required to maintain
Ht level at 35% are not higher than doses usually administered to
patients on CHD. (3) In our experience, rHuEPO therapy does not
seem to worsen MM evolution.
Effects of acetate (AHD), bicarbonate hemodialysis (BHD) and acetate
free biofiltration (AFB) on left ventricular systolic and diastolic functions
in chronic dialysis patients (CDP). P. Ruedin, J. Sztajzel, C. Stoermann,
J. Schifferli, W. Rutishauser, R. Lerch, M. Leski, Division of Nephrol-
ogy and Cardiology Center, University Hospital, Geneva, Switzerland.
To study the influence of altered volume loading and buffer composition
on cardiac function, indices of left ventricular (LV) systolic function
and diastolic filling hemodynamics were determined by Doppler echo-
cardiography immediately before and after hemodialysis (HD) using
AHD, BHD and AFB successively, in 12 CDP (40.8 2.7 years [x
SEMI) without overt cardiac disease. Duration of dialysis and weight
loss were comparable for the 3 types of dialysis. The decrease in mean
blood pressure was comparable for the 3 methods, averaging 5 4, 7
5 and 10 4 mm Hg in AHD, BHD and AFB, respectively (NS). Heart
rate increased in AHD (from 69 3 to 81 3 beats/mm; P < 0.005) but
remained unchanged in BHD and AFB. LV ejection fraction was
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normal before (63.1 2.9, 58.0 0.3 and 57.0 1.3% in AHD, BHD
and AFB, respectively) and did not change significantly (61.4 3.3,
60.0 0.7 and 58.0 0.7%) after HD. However, in each case there was
a characteristic change of the transrnitral diastolic flow velocity pattern
monitored by pulsed Doppler:
B (early rapid atrial
filling velocity)
cm/sec TPI/2 (pressure half-time) msec
Before HD After HD Before HD After HD
AHD 95.8 8.0" 76.9 9.9 62.6 4.9" 88.7 6.2
BHD 95.3 8.2" 63.0 5.7 74.3 6.2a 100.8 7.9
AFB 95.6 6.1" 72.5 5.5 72.4 8.6 NS 84.1 8.1
A (late atrial filling velocity) cm/sec
Before HD After liD
AND 79.3 6.0 NS 71.0 6.0
BHD 79.7 6.3 NS 74.1 4.7
AFB 80.0 6.2 NS 78.5 3.4
ap <0.05
b P < 0.01
No significant difference was found between groups.
In conclusion: (1) Hemodialysis markedly affects the transmitral flow
velocity pattern providing further evidence for the pronounced preload-
dependence of Doppler indices of LV diastolic function. (2) Modifica-
tions of LV filling pattern were comparable except for the pressure
half-time (TPI/2) which significantly increased after AHD and BHD but
not after AFB implying that diastolic function was less affected after
AFB. (3) In CDP with no overt cardiac dysfunction, the different buffer
systems do not affect systolic LV function.
Pharmacokmetic study of dcli in HIV seropositive asymptomatic sub-
jects with normal or impaired renal function. E. Singlas, 0. Parent,
A.M. Taburet, F. Borsa-Lebas, G. Humbert, A. Sobel, A. Benmaadi,
R. Alkhayat, B. Viron, C. Naret, S. Delons, fL. Poignet, I. Etienne,
and J.P. Fillastre, Department of Clinical Pharmacy, Paris, Depart-
ment of Infectious Diseases, Rouen, Department of Nephrology, Paris
and Rouen, France. ddl (2',3'-dideoxyinosine) is a purine analogue and
is used to treat patients with acquired immune deficiency syndrome
(AIDS) or severe AIDS-related complex (ARC). Renal elimination
plays an important role in the disposition of ddl. The drug is eliminated
by glomerular filtration and by tubular secretion. Since glomerulone-
phritis with renal insufficiency is a possible manifestation of HIV
infection, data in subjects with severe renal impairment are necessary
to determine what dose adjustments may be required in these patients.
Two groups of seropositive HIV patients were studied. Group I or
control group included 6 patients with normal renal function. Group II
included 4 patients with severely impaired renal function requiring
hemodialysis. These patients were studied twice (on and off dialysis).
Each patient received a 375 mg oral dose of ddl. Hemodialysis was
initiated 3 hours after the administration of ddl. Thirteen blood samples
were collected from 0 to 30 hr after drug administration. Hemodialysis
was performed with a constant blood flow rate of 300 mI/mm and
dialysate flow rates of 500 ml/min. Concentrations of ddl in plasma,
urine and dialysate were assayed by HPLC.
Cmax
ag/ml
tmax t-1/2
hr
AUC
p.g
hr/mi
Oral
clearance
mi/mm
Group I 2.1
1.1
0.7
0.2
1.2
0.2
3.0
1,3
2448
1086
Group!! 4.5 1.1 3.3 13.2 508
off 2.1 0.7 0.3 3.5 182
dialysis
Increased half life (t 1/2) and decreased clearance of ddl in patients with
severe renal impairment are in agreement with the renal excretion of
ddl which accounts for 30 to 40%. Extraction ratio by the dialyzer was
43 18% and hemodialysis clearance was 86 33 ml/min.
Determinants of reflex natriuresis following bilateral carotid artery
traction (BiICAT) in the rat. f-P. Valentin, S.A. Mazbar, and M.H.
Humphreys. Division of Nephroiogy, University of California San
Francisco, San Francisco, California, USA. Activation of carotid sinus
baroreceptors results in reflex vasodepression. We observed that inter-
mittent (first minute of each 15 mm period for six periods) manual
traction applied to both carotid arteries produced a transient fall in
arterial pressure (AP) of 28 3 mm Hg from a value of 121 3mm Hg
and led to progressive natriuresis that was fully developed 45 to 90 mm
after initial application of Bi1CAT. Sodium excretion (UNaV) increased
from a control of 3.2 0.4 to 5.3 0.5 LEq/min (P < 0.001) and
potassium excretion (UKV) from 2.7 0.2 to 3.3 0.2 Eq/min.
BiICAT also increased GFR (clearance of iothalamate) from 2.9 0.2 to
3.5 0.2 ml/min (P < 0.02) and fractional excretion of lithium (FELt)
from 22.8 4.1 to 31.3 4.4%. Rats undergoing sham traction showed
no change in either GFR or cation excretion over the 90 mm study
period. To test whether the renal nerves constituted the efferent limb in
this reflex natriuresis, we carried out intermittent BiICAT in 7 rats with
acute and 7 rats with chronic bilateral renal denervation; results were
similar and have been pooled. BiICAT now failed to increase either
UNaV (3.6 0.8 to 2.9 0.7 sEq/min) or UKV (2.3 0.3 to 2.1 0.2
Eq/min) (P = NS for each) despite a comparable fall in AP of 26 3
mm Hg from a value of 106 4 mm Hg. Moreover, no change in GFR
(2.4 0.2 to 2.3 0.2 mI/mm) or FELl (26.9 3 to 26.2 2.6%)
occurred. BiICAT elicits a reflex natriuresis that is dependent on renal
innervation, suggesting that a decrease in efferent renal nerve activity
constitutes the efferent limb of the reflex. The failure of GFR as well as
UNaV to increase after BiICAT in denervated kidneys raises the
possibility that the renal nerves may mediate this reflex natriuresis
through a hemodynamic effect on GFR.
Displacement of labeled atrial natriuretic peptide (ANP) from renal
binding sites by urodilatin (URO). 1.-P. Valentin, L.A. Sechi, C. Qiu,
M. Schambelan, and M.H. Humphreys. Divisions of Nephrology and
Endocrinology, University of California San Francisco, San Francisco,
California, USA. URO is a recently described member of the ANP
family, thought possibly to be synthesized in the kidney. To determine
if URO binding sites are present in rat kidney, we evaluated the effect
of URO on '25!-ANP (100 pM) binding to frozen sections using an in situ
autoradiographic technique. '251-ANP binding occurred primarily in
glomeruli and medullary structures. Increasing concentrations of URO
yielded a monophasic displacement curve with an IC50 of 4.2 n, a
value nearly identical to that achieved with unlabeled ANP (7.2 nM). In
additional experiments, rat inner medullary collecting duct cells were
isolated and incubated in vitro with either ANP or URO (lOhI_10_6 M),
and cyclic GMP production was measured in the supernatant following
TCA precipitation. Dose-response curves for the two peptides were
superimposable; at 106 M, ANP generated 613 41 and URO 603 55
fmol cGMP/l0 mm/mg protein (P = NS). Thus, URO is as effective as
ANP in displacing '25I-ANP binding to renal tissue and in generating
cGMP in target cells, suggesting that its physiological effects may occur
through the same receptors and signalling pathways which mediate the
actions of ANP.
Cellular basis of blunted volume expansion (VE) natrluresis in adri-
amycin (ADR) nephrotic rats. 1.-P. Valentin, C. Qiu, M. Rana, W.P.
Muldowney, D.G. Gardner, and M.H. Humphreys, Division of
Nephrology and Metabolic Research Unit, University of California San
Francisco, San Francisco, California, USA. ADR injection (7.5 mg/kg
i.v.) in rats leads in 3 to 5 weeks to proteinuria, blunted VE natriuresis,
and impaired responsiveness to infused atrial natriuretic peptide (ANP).
Whether the blunted natriuresis is due to enhanced proximal reabsorp-
tion with impaired distal delivery of filtrate or to an inability to reduce
distal reabsorption in response to YE remains controversial. An acute
saline load (2% body weight iv. over 5 mm) increased FENa from 0.5 to
2.9% (P < 0.001) within 30 mm in control (CTL) Sprague-Dawley rats;
ADR nephrotic rats started from a similar baseline but had a blunted
increase (P < 0.02) in response to VE (0.3 to 1.7%) despite an even
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higher plasma ANP concentration after VE (311 35 vs. 201 27
pg/mi, P < 0.05). ADR animals also had lower FEL, both before and
after VE (18.6 to 24.4% vs. 27.6 to 38.8%, P <0.05 for each), suggesting
that increased proximal reabsorption and reduced distal delivery could
contribute to the blunted natriuresis. Urinary cGMP excretion in-
creased from 24.6 to 73.9 pmol/min in CTL rats (P < 0.02) but only from
22.0 to 36.9 pmol/min in ADR rats (P < 0.02 CTL vs. ADR), indicating
diminished generation of cGMP in response to YE in nephrotic kidneys.
Inner medullary collecting duct (IMCD) cells isolated from CTL and
ADR rat kidneys and incubated in vitro with ANP (l0- M) generated
536 64 and 226 36 fmol cGMP/10 mm/mg prot (P < 0.01 CTL vs.
ADR). Glomeruli isolated from CTL and ADR rat kidneys and incu-
bated in vitro with ANP (10 M) generated 563 105 and 295 31 fmol
cGMP/10 mm/mg prot (P < 0.01 CTL vs. ADR). These studies indicate
that the cellular basis for ANP resistance in ADR nephrosis is impaired
generation of cGMP in glomeruli and IMCD cells. This resistance could
contribute to blunted VE natriuresis in this form of nephrotic syn-
drome. In addition, reduced distal delivery of filtrate, inferred from the
smaller increase in FELL after YE, also exists in this model. Thus, both
proximal and distal defects could participate in altered sodium handling
in ADR nephrosis.
High-dose acyclovir for the prophylaxis of cytomegalovirus (CMV)
infection in renal allograft recipients. T. Wong, 0. Toupance, S.
Lavaud, J. Carquin, A. Wynckel, M. Fakir, and J. Chanard, Service de
Nephrologie et Laboratoire de Bacteriologie-Virologie, Centre Hospi-
talier Regional et Universitaire de Reims, Reims, France. Human
cytomegalovirus is a major opportunistic pathogen following organ
transplantation. Recent efforts have been focused mainly on finding
cost-effective preventive strategies while awaiting more active antiviral
drugs. In one placebo-controlled trial conducted in recipients of renal
allografts, high-dose oral acyclovir significantly reduced CMV infection
and disease rates. On the basis of these results, we enrolled 21 renal
transplant recipients in an open-label trial to receive high-dose oral
acyclovir for 3 months. Patients at low risk of developing CMV
infection (donor-negative/recipient-negative pairs: D—R—) were ex-
cluded from the study and care was taken that they receive only
screened CMV-negative blood products. Acyclovir was administered
intravenously at an initial dose of 5 mg/kg within the 6 hours prior to
surgery, and subsequent oral doses of 800 mg were given according to
the patient's estimated creatinine clearance: 6-hourly, 8-hourly and
24-hourly if the creatinine clearance was >25, 10—25 and <10 ml/min/
1.73 m2, respectively. CMV infection, defined as laboratory evidence of
active CMV replication, was documented in 17 patients (8 1%) and CMV
disease (symptomatic infection) in 8 (38.1%), including 2 with severe
interstitial pneumonitis. Historical controls had significantly lower
infection incidence: 12 of 32 patients (38.1%). Disease rate, although
lower in historical controls (25%), was not statistically different (P =
0. 10) from that of treatment group. Only one patient out of 19(5.3%) in
the D—R— group developed CMV infection. On the basis of these
results, we consider that high-dose oral acyclovir does not protect from
CMV infection in our setting and that the use of screened CMV-
negative blood products can be a safe and cost-effective preventive
strategy in D—R— recipients.
Low molecular weight heparin and slow continuous hemodialysis. A.
Wynckel, 0. Toupance, P. N'Guyen, J.P. Melin, G. Brillet, T. Wong,
and J. Chanard, Service de Nephrologie et Laboratoire d'Hématolo-
gie, Centre Hospitalier Regional et Universitaire de Reims, Reims,
France. Anticoagulation, which is necessary for slow continuous he-
modialysis (SCH), can lead to bleeding complications in critically ill
patients. Low molecular weight heparins (LMWH) are now being used
successfully in intermittent hemodialysis (IH). The aim of the study was
to evaluate enoxaparmn (Lovenox') in SCH. Enoxaparin is a LMWH
(4.5 to S Kd) characterized by an anti-XaJanti-IIa activity ratio higher
than four. In order to define adequate anticoagulation in SCH, optimal
doses of enoxaparin were estimated from results obtained in treating
acute renal failure in IH: anti-Xa activity (measured on chromogenic
substrate) higher than 0.25 lU/mi at the end of hemodialysis was
necessary to prevent thrombosis. The following regimen was tested:
initial pulse of 40 mg then intermittent administration of doses between
10 and 40 mg every 6 hours (hr) in order to maintain anti-Xa trough
activity between 0.25 and 0.50 lU/mI. Fourteen patients hemodialyzed
for more than 24 hr were included. Initial thrombocyte count was less
than 50 x 109/liter in seven patients. Eleven had a prolonged initial
activated partial thromboplastin time (APTT). AN 69S (0.50 m2) filter
was ideally changed every day (mean duration 22.8 7.5 hr. N = 48).
Clotting of the extracorporeal circuit was noted in 4 cases when anti-Xa
activity was less than 0.2 lU/mi. In thirteen patients, anti-Xa activity
was 0.43 27 lU/mi (N 103). It was 1.46 0.16 lU/mi (N = 16) in
the fourteenth patient. No side effect was observed. A linear relation-
ship was found between observed APTT/initial APTT ratio and anti-Xa
activity (r = 0.5; P = 0.0001). Initial daily dose of enoxaparin was 1.85
0.80 mg/kg/i. For prolonged SCH, doses had to be lowered (by an
average 21% of the initial value after 72 h). In conclusion, enoxaparin is
suitable for SCH. An anti-Xa trough activity between 0.25 and 0.50
lU/mi can prevent clotting without bleeding complications.
Crossover comparison of hemostatic disturbances induced by two
hollow-fiber hemodialysis membranes, polyacrilonitrile and polyamide.
C. Stoermann, G. Reber, P. Ruedin, P. de Moerloose, and M. Leski,
Nephrology Division and Haemostasis Unit, Geneva University Hos-
pital, 1211 Geneva 4, Switzerland. The effect on hemostasis of two
hollow-fiber dialysis membranes, polyamide (PAM, Polyflux) and poly-
acrylonitrile (PAN, Filtral), was analyzed in a crossover study involv-
ing ten chronic hemodialyzed patients. The wash-out period was one
month. Changes in primary hemostasis (platelet count and /3-thrombo-
globulin f3TG), coagulation (thrombin-antithrombin III complexes TAT,
fragment F! + 2 and fibrinopeptide A FPA) and fibrinolysis (t-PA ag,
PAl act, PAT-i ag and D-dimer) were compared. Blood samples were
obtained at both arterial and venous lines before dialysis and at 15, 30
and 180 mm. Anticoagulation with heparin (as estimated by APTT and
anti-FXa assay) was similar in both groups. PAM induced a significant
initial decrease in platelet count but at 180 mm there was no difference
between the two membranes. An elevated I3TG release was induced by
PAM, the difference with PAN being significant at all time-points. Up to
30 mm PAM /3TG venous values were higher than arterial values.
Activation of coagulation by PAN was more pronounced albeit not
statistically different from that caused by PAM, as shown by higher
TAT and FPA levels throughout the dialysis period. Both venous and
arterial TAT and FPA increased regularly with time with both mem-
branes. With PAM an early t-PA and PAT-I release occurred, not
observed with PAN. PAl activity decreased with both membranes.
D-dimer levels were similar. In conclusion, the individual responses to
membranes were wide. A significant initial platelet activation by PAM
was observed. Although not significant, a release of fibrinolytic com-
ponents by PAM occurred.
Post-catheterism vein stenosis in hemodialysis: comparative angio-
graphic study of 50 subclavian and 50 internal jugular accesses. F.
Schillinger, D. Schillinger, R. Montagnac, and T. Milcent, Depart-
ments of Nephrology, Hemodialysis and of Radiology, General Hospi-
tal of Troyes, France. Among the complications of temporary vascular
accesses necessary to dialysis when an artenovenous fistula is not
functional, the strictures of the subclavian-brachiocephalic vein are of
frequent risk to limit venous access of dialyzed patients. From January
1986 to December 1990, we studied angiographically the subclavian-
brachiocephalic vein of 100 patients dialyzed on subclavian catheter for
50 (first group) and on internal jugular catheter for 50 others (second
group). These 2 groups were not statistically different for age (61.6
11.3 years in the first and 61 11.1 in the second), for sex (respectively
48% and 56% of women), for time length of catheter insertion (respec-
tively 31 21.8 days and 31.7 16), and for number of dialysis sessions
(respectively 13.5 9.1 and 13.6 7.1). The type of catheters, the
frequency of removal for poor flow (16% in both groups) or for
infections (6% in both groups) and local nursing were similar in the 2
groups. Only the side of cannulation differed but not significantly: the
right side in 58% of cases in the first group and 78% in the second. The
angiographic study revealed stenosis of the vein in 42% of the subcla-
vian group and in 10% of the internal jugular group. The left side
presented more risks of stenosis than the right, which can be explained
by anatomical features. The strictures, whose severity was variable,
were mainly located at and slightly above the junction of jugular and
subclavian veins. This significant difference in favor of the internal
jugular route shows its superiority over the subclavian route for venous
access in dialyzed patients.
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Specific increase in the plasma concentration of peptides arising from
the N-terminal fragment (NTF) of pro-opiomelanocortin (POMC) follow-
jug acute unilateral nephrectomy (AUN). C. Qiu, J.-P. Valentin, X.-W.
Chen, E. Wiedemann, and M.H. Humphreys, Divisions of Nephrology
and Endocrinology, University of California San Francisco, San Fran-
cisco, California, USA. Reflex natriuresis after AUN is related to an
increase in plasma concentration of a peptide (s) closely related to
gamma-melanocyte stimulating hormone (g-MSH). g-MSH resides in
the NTF at amino acid position NTF512. We compared the pattern of
changes in plasma immunoreactivity of g-MSH, an adjacent peptide
NTF32'9, and ACTH by assay of extracted plasma using highly specific
antisera raised against these epitopes, and related them to the increase
in sodium excretion (UN8V) following AUN. Results (mean SEM):
Sham
AUN
Minutes after-AUN
30 60 90 120
UNaV 0.21
0.11
0.66
0.28a
1.00
0.24a
0.94
0.16
0.86
o.17a
g-MSH 14,4
1.5
21.9
2.1
20.8
5.5
25.6
5.0
25.7
42b
NTF 14.0
1.8
25.3
3.1
19,1
2.0
20.4
1.9
27.1
49b
ACTH 87.4
7.1
106.7
7.1
92.3
7.7
86.6
8.3
93.0
5.5
UNaV, Eq/min; g-MSH, NTF329 and ACTH, fmol/ml. a p < 0.05
significant increase over control; ' P < 0.05 significantly greater than
sham AUN by ANOVA.
UNaV was significantly increased throughout the two-hour study pe-
riod. The concentrations of g-MSH and NTF329 rose after AUN and
the values at 120 mm were significantly increased. There was no
significant change in plasma ACTH concentration, These results pro-
vide evidence for a differential effect of AUN on POMC-derived
peptides, suggesting preferential secretion of peptides residing in the
NTF over ACTH release and supporting a role of such peptides in
postnephrectomy natriuresis.
Cydosporin toxicity after renal transplantation: Proton NMR study of
urine. A. Pruna, L. Le Moyec, J. Bedrossian, M.C. Moal, f.M. Ida ftc,
and M. Eugene, Laboratoire de RMN et Exploration Fonctionnelle,
Sce de NEphrologie, Hôpital Saint-Louis, Paris, France. Cyclosporin
A (CsA) nephrotoxicity is not systematically related to CsA plasma
levels (pCs). With 1H-NMR, nephrotoxicity of many substances has
already been assessed. However, no extensive study of CsA adverse
effects has been performed. We observed 28 cadaveric renal transplant
recipients from Dl to D30 after transplantation. All patients were taking
2 to 8 mg/kg/day CsA. CsA plasma levels and usual blood and urine
biological parameters were correlated with NMR data. 1H-NMR spec-
tra of urine samples were acquired on a AM400WB Bruker spectrom-
eter at 400 MHz, with water suppression. Results. Patients were
separated into 2 groups according to renal function recovery: Group I
(N = 18) with creatimne clearance >20 mllmin from D2, Group 2 (N =
10) who needed hemodjalysis from Dl to D21. Spectra which could be
identified in urine were leucine valine alanine acetate lactate citrate
creatinine sugars and trimethylamine-n-oxide. An unidentified reso-
nance at 3.7 ppm chemical shift was found in all patients taking CsA. Its
identification is currently in progress. It is neither due to CsA itself nor
to one of its metabolites. With respect to its chemical shift, this
substance could belong to glycurono conjugates glucuronides or to
glycosaminoglycans. Its intensity varies with pCs in a different manner
in the 2 groups: in group I there is a correlation between the values of
these 2 parameters whereas in group 2 the 3.7 ppm peak can be high
despite low-normal pCs. Hence, its intensity reveals CsA nephrotoxic-
ity even when pCs are low. Conclusion: IH-NMR spectroscopy of urine
is a noninvasive, accurate and easily carried out technique to assess
CsA toxicity in renal transplanted patients.
Ion H' is an inappropriate unit for acid (A)-base (B) problems in
medicine: Proposition for a double scale. M. Petrover, Centre d'Hé,no-
dialyse, Clinique de l'Orangerie, Aubervilliers, France. The unit scale
used in A-B physiology as in A-B disorders must be adequate for the
compartmental model where this process takes place. More precisely, it
has to allow quantitative evaluation of the intra-compartmental con-
tents as for the transfers determining them. For this purpose, from the
beginning of the sixties, ion H has been selected as a central unit. This
choice, based on a misconception of the Bronsted theory (1923), an
error pointed out at that time but forgotten thereafter, is totally
inappropriate. The reasons are: (1) the unique properties of the ion H
(radius l0', mobility—through Grotthus mechanisms: 3 times more
than for other ions, etc.), meaning that not only does it differ from other
electrolytes but it does not exist in aqueous solutions (except in very
different contexts during transition-states developed in ultra-fast and
ultra-microscopic domains, during proton transfers; in A-B reactions,
through biological membranes with proton-pumps, H-ATPase, cy-
tochrome oxidase, etc.); (2) the partial representativity—through the
sun free plus bound acidity—of the chemical species which are con-
cerned: A and B themselves; (3) the non-appreciation of the deep
meaning of the pH, interpretated as a mathematical artifice whose goal
is only to prevent the use of long decimal numbers, allowing its
conversion in "concentration of free ions H" (but which is in fact and
index of chemical potential, in the sense given by W. Gibbs, i.e. an
intensive parameter, in the same way as temperature and pressure) the
logarithmic writing being only the expression of fundamental thermo-
dynamic laws; (4) more generally, the physical-chemistry nonsense of
concepts such as "ion H balance" or "protonic" when applied to
living individuals. Conclusion: For medical purposes where goals are to
give the mental and practical tools permitting the representation and the
evaluation of A-B process: (1) the ion H—the bare proton—is totally
illegitimate; (2) another approach, allowing quantification of A-B mate-
rial but conserving the singular unit pH, is necessary. Expanding the
classical duality, free and titrable acid, but giving it a very different
sense, it is based on the specification and the description of the
intra-compartmental contents and the transfers with the help of the
same macroscopic parameters as those used in classical thermodynam-
ics. As they are divided in 2 classes, 2 systems must jointly operate: (a)
the first system is devoted to evaluate quantity of material by extensive
parameters/molar units, that is, mmol of A or B (more precisely, their
fraction which dissociates at body pH and is known by its pK) and
where the chemical nature must be explicitly stated. Because it offers a
"corpuscular representation" of the intra-compartmental contents, this
system is a privileged descriptor for A-B physiology and pathophysiol-
ogy; (b) the second system's role is to inform on the state of material,
described by intensive parameters. The pH which is connected to free
energy variations, by being an effective measure of a potential, is able
to fill this function,
Renal epithelial cells In culture: A comparative study of the functional
activities of rabbit kidney proxhnal tubule cells in primary cultures and
the LLC-PK1 and OK cell lines. J.P. Morin, C. Monteil, B. Moulin, and
J.P. Fillastre, INSERM U-295, Universite de Rouen, France. A pri-
mary culture is developed from calibrated fragments on highly purified
proximal tubules isolated from rabbit kidney. These cells are grown in
DMEM/Ham Fl2 medium, fortified with sodium selenite, human trans-
ferrin and hydrocortisone, either (1G) without insulin or glucose or
(IG) with insulin and glucose 5 mi and insulin 5 mg/ml. LLC-PK1
and OK cells were grown in either PG medium or in DMEM-Ham F12
medium glucose 5 mivi fetal calf serum 5% (FCS). Except for the first 72
hours in primary cultures, all cells were grown in the absence of
antibiotic and antifungal agents. Cells were harvested at confluency of
the monolayer. Intracellular activities of NaIK-ATPase (NAK), succi-
nate dehydrogenase (SDH), N-acetyl-/3-D-glucosaminidase (NAG),
cathepsin B (CAT), y-glutamyl transpeptidase (GT), alkaline phos-
phatase (ALP), alanine aminopeptidase (AAP), lactate dehydrogenase
(LDH), glutathione-S-transferase (GST), methylglucoside transport and
tritiated leucine incorporation were assayed as relevant markers of
cellular functions. No effect of culture condition was seen for )QT,
ALP, NAK, SDH, NAG, CAT or GST activities in LLC-PK1 cells.
Decreased methylglucoside transport and protein synthesis were seen
in IG medium as compared to FCS medium in LLC-PK1 cells. OK
cells exhibit extremely low levels of brushborder enzymes and methyl-
glucoside transport. Decreased activities of NAG and SDH were seen
in IG medium compared to FCS, while other parameters were
unaffected by culture conditions. Primary cultures exhibit high levels of
GST compared to LLC-PK1 or OK cell lines, Increased brush border
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activities were seen in 1G — compared to IGt No effect of insulin and
glucose was seen on SDH, GST, NAG and CAT. Slightly decreased
protein synthesis, LDH and NAK activities were seen, while slightly
increased methylglucoside transport was seen in 1G cultures. In
conclusion, much care should be taken as to the expressed cellular
phenotype that may extensively vary according to cell type or culture
conditions.
Acetate-free bicarbonate dialysate. N.K. Man, A. Saada, Ch. Rou-
quette, C. Nelas, and J. Zingraff, Departement de Nephrologie,
Hópital Necker, Paris, France. The so-called 'acid" concentrate
solution usually contains 2 to 6 mmol/liter of acetic acid which are
required to maintain the dialysate pH between 7.3 to 7.5, in order to
prevent calcium carbonate and magnesium carbonate formation and
precipitation in the bicarbonate dialysate. However, it was recently
shown that acetate, even at these minimal concentrations, is able to
stimulate mononuclear cells and cytokine release. To suppress these
potential adverse effects, hydrochloric acid was substituted for acetic
acid in the "acid" concentrate solution for the preparation of bicarbon-
ate-containing dialysate. For clinical trial, using a Cobe Centrysystem 3
dialysate delivery system, appropriate concentrate solutions were pre-
pared, having the following composition: "acid" concentrate solution(1/45): Na 100, K 2, H 4, Ca 1.75, Mg 0.75, C1 Ill
mmol/liter; "bicarbonate" concentrate solution (1/26.2): Na 39,
HCO 39 mmol/liter (Soludia, Fourquevaux, France). In vitro experi-
ments have shown that the dialysate composition is stable, at least
during 6 hours, and the concentration of heavy metals does not exceed
1 ppm (N = 13). Twelve dialysis sessions, lasting 4 hours each, were
performed in 9 patients without noticeable incident. For a dialysate
composition prescription of bicarbonate at 35 mmol/liter and of sodium
at 142 mmol/liter, pre- and post-dialysis concentrations (mean SEM,
mmol/liter) of bicarbonate, sodium and calcium in blood and in dialy-
sate in 6 sessions, are shown in the Table.
Pre-dialysis Post-dialysis
Blood Dialysate Blood Dialysate
Bicarbonate 19.4 0.4 31.7 0.2 23.6 0.9 32.1 0.9
Sodium 139.0 1.1 144.5 1.4 143.5 0.7 143.2 0.3
Calcium 2.33 0.05 1.91 0.03 2.96 0.09 1.92 0.02
Dialysate analysis showed a drift of the "bicarbonate" pump of about
—9% (31.9/35 = 0.91). This deficit was compensated by the "acid"
pump in the same magnitude (1.915/1.75 = 1.09), giving a final dialysate
which contains a relatively high calcium concentration. Using the same
method, theoretical sodium concentration in final dialysate could be
calculated ("bicarbonate" pump: 39 x 0.91 = 35.5 mmollliter; "acid"
pump: 100 x 1.09 = 109 mmol/liter; final dialysate sodium concentra-
tion: 35.5 + 109 = 144.5 mmol/liter), which is similar to measured
dialysate sodium concentrations. This observation emphasizes the fact
that one should be aware of various consequences resulting from the
utilization of dynamic proportioning system for the preparation of
bicarbonate dialysate. The results demonstrated clearly that the addi-
tion of 180 mmol/liter HCI to "acid" concentrate solution (1/45) allows
the preparation of a stable bicarbonate-containing dialysate which
behaves similarly to that with acetic acid, at least for the duration of the
dialysis session. However, further studies are needed to demonstrate
the clinical benefit of using an acetate-free bicarbonate dialysate.
Respective role of age and chronic renal failure (CRF) in thyroid
abnormalities in dialysis patients. A. Koita, B. Viron, J.P. Vincent, F.
Mentré, C. Michel, C. Albert, R. Féron, and F. Mignon, Service de
Néphroiogie, Hôpitai Tenon, Service de Gériatrie, Hôpitai Joffre,
Draveil, Département de Biomathénatiques, CHU Pitié, Service d'En-
docrinologie, Hopitai Saint-Antoine, Paris, France. CRF patients
usually have low-normal values of T3 and T4 associated with high-
normal TSH. On the other hand, the high incidence of silent thyroid
dysfunction in the elderly is well-known. Nevertheless, the effect of the
association of age and CRF on thyroid function has never been studied.
We thus measured free T3, free T4 and ultrasensitive TSH in (a) 95 CRF
patients free of endocrine pathology and receiving no drugs capable of
altering hormonal assay; 51 patients were on hemodialysis (HD) and 44
on peritoneal dialysis (PD). According to their age, these patients were
divided into two groups: group 1 <70 years (42 men, 23 women, mean
age = 52 12); and group 2  70 years (14 men, 16 women, mean age
= 79 5). (b) 14 controls > 70 years (6 men, 8 women, mean age = 81
5) free of disease (group 3). Their mean creatinine clearance was 55
11 mI/mm. The following results (mean SD) were collected:
T3 pg/mi T4 ng/lOO ml log TSH
(I) CRF <70 2.22 0.53 0.83 0.26 0.12 0.35
(2) CRF 70 2.58 3.42 0.87 0.26 0.07 0.58
(3) Ctrl. 70 2.82 0.92 1.08 0.24 0.08 0.49
(4) Ctrl. lab 3.84 0.99 1.34 0.31 —0.2 0.004
P(l) vs. (4) <0.001 <0.001 <0.001
P(2) vs. (4) <0.05 <0.001 <0.01
P(3) vs. (4) <0.001 <0.001 <0.05
P(l) vs. (2) NS NS NS
P(2) vs. (3) <0.01 <0.01 NS
We conclude that old age alone can be responsible for abnormalities
(low T3 and T4, high TSH) similar to those found in CRF. In the
absence of any clinical symptoms, these data should not be interpreted
as a thyroid disease and no treatment should be attempted. However,
when associated with CRF, age does not consistently amplify the
thyroid abnormalities owing to CRF, and therefore plays a minor role in
elderly CRF patients.
What are target values for hemoglobin (fib) and hematocrit (Hct) in
hemodialysis (lID) patients during erythropoietin (EPO) therapy? V.
Joyeux, P. Le Pogamp, A. Moisan, and D. Hamel, Nephrology,
Nuclear Medicine, Rennes, France. HTA and vascular thrombosis, the
most frequent complications of EPO therapy in HD patients, are not
dose-dependent, but probably related to the effects of EPO treatment,
especially the increasing of red blood cell (RBC) mass and whole blood
viscosity. What target values for Hb and Hct to choose to adjust EPO
therapy? Pre-dialytic Hb and/or Hct are perhaps poor indicators for
RBC mass estimation, because of frequent fluid inflation: Are post-
dialytic Hb and/or Hct more reliable, because they are assessed at 'dry'
weight? Are the usual target values of 10 gIdl for Hb and 30% for Hct
good reflections of RBC mass? In 55 cases, one hour after the session
end at 'dry weight,' we measured by isotopic method, RBC mass
(Chrome 51), plasma volume (lode '25-Albumin) and whole blood
volume. We studied the correlation of these values to Hb and Hct
determined before dialysis, after dialysis and one hour after blood
recovery. First, RBC mass was more often underestimated when we
refered to predialytic Hb and Hct: 16/55 cases (29%) rather postdialytic
Hb and Hct: 7/55 cases (13%) (CHI 2: P < 0.02). Second, RBC mass
was sometimes overestimated when we refered to predialytic Hb and
Hct (3/55 cases) or postdialytic values (5/55 cases) (chi2: NS). Third,
there was no significant difference between Hb and Hct values mea-
sured at the end of session (before blood recovery) and those measured
one hour after. Lastly, usual target values for Hb and Hct are poor
reflections of RBC mass in 20 to 35% cases: difilculties in clinical 'dry'
weight estimation might explain these facts. We conclude that postdi-
alytic Hb and Hct values seem to be more reliable; underestimation of
RBC mass is dangerous because it leads to increased EpO therapy.
Relevance of 3 cross match (CM) techniques to renal transplantation:
Standard lymphocytotoxicity assay (SLACM), LA on antibody coated
microspheres (LAACM) and flow cytometric cross match (FCCM). B.
Hory, P. Hérvé, Y. Saint-Hillier, and C. Pérol, Unit of Nephrology,
Blood Bank, C.H. U. 2, Besancon, France. Among 65 patients trans-
planted, 13 presented a positive cross match on current serum with at
least one of the 3 techniques. Seven CM were positive with SLACM at
4,22 or 37°C, 5 with LAACM (all B), 6 with FCCM (3T, 2B and I B and
T). 1GM antibodies were detected with dithiotreitol in 6 patients but
none had only 1GM and 5 patients had positive historical cross match.
Two CM were negative using SLACM but positive with LAACM (one
kidney lost), 4 CM were positive using SLACM and negative with
LAACM (one kidney lost), 5 CM were positive using SLACM and
negative with FCCM (1 kidney lost) and 3 CM were positive using
FCCM and negative with SLACM (2 kidneys were lost). FCCM and
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LAACM are more rapid than the conventional cytotoxic test. They
could represent complementary techniques for selection of transplant
recipients.
Human immunodeficiency virus infection and maintenance dialysis. L.
Fromentin, C. Michel, B. Viron, C. Albert, and F. Mignon, Service de
Nephrologie, Hôpital Tenon, Paris, France. We evaluated 14 patients
with HIV infection who had begun maintenance dialysis for end-stage
renal disease from January 1, 1986, to September 1, 1990 in our center.
During hemodialysis sessions, precautions applied to control hepatitis
B virus transmission were used and HIV patients were not isolated. The
medical records of each patient were reviewed for initial nephropathy,
risk factors, staging of HIV infection at the beginning of dialysis, and
outcome on maintenance dialysis (complications, antiviral treatment).
The serum of all other chronic dialysed patients and 4 staff members
who had accidental exposure to HIV infected blood were tested for
HIV antibody every 6 months. The analysis was stopped on May 30,
1991. Group 1 included 9 patients with HIV associated nephropathy (8
men, 1 woman, mean age 35.1 5.1 years). At the beginning of dialysis,
4 patients were asymptomatic seropositive HIV carriers, 3 had ARC
and 2 had AIDS. The AIDS patients died after 4 and 6 months of
chronic hemodialysis [mycobacteria septicemia (1), HIV encephalopa..
thy (1)]. For the 7 asymptomatic or ARC patients, the mean survival
time was 16.1 6.2 months; three of them died [septic shock (1),
disseminated tuberculosis (1) and HIV encephalopathy (2)]. Group 2
comprised 5 patients (2 men, 3 women; mean age 37.6 7.3 years) with
chronic renal failure from various non-HIV-associated nephropathies.
Contamination by blood transfusion was documented in 3 patients. At
the time HIV seropositivity was diagnosed, 3 patients were asympto-
matic seropositive HIV carriers, 2 had ARC. The mean survival time
after diagnosis of HIV infection was 40.6 11.6 months. One patient
died of epileptic encephalopathy. Eight patients were treated with
zidovudine (mean dose 300 mg per day), 2 of them developed severe
leukoneutropenia. No seroconversion was observed among the sero-
negative HIV dialyzed patients or staff members. The clinical stage of
infection is the main determinant of survival in HIV infected patients
with chronic renal failure. Maintenance dialysis provided meaningful
and long-term life support in HIV asymptomatic and ARC patients in
group I. The survival rate of dialyzed patients in group 2 was similar to
that reported for HIV patients without renal failure; chronic renal
failure does not seem to modify the prognosis of the disease.
IgA nephritis: On the importance of the first clinical symptoms at
diagnosis. L. Frimat, B. Aymard, D. Mayeux, D. Hestin, E. Renoult, S.
Briancon, M. Kessler, France. This prospective study aimed to show
the importance of clinical parameters when the diagnosis of IgA
nephritis is made. From October 1988 to March 1991, 59 IgA nephritis
occurred in 51 men and 8 women, mean age 41 years (15—29: 20, 30—44:
14, 45—59: 14, >60 years: 11). The histological gradings (LEE's classi-
fication) were: 1 and II: 30, III: 15 and V: 14. First clinical symptoms
are in 83% of our patients proteinuria, 75% microscopic hematuria, 35%
hypertension (H), 33% gross hematuria, 25% elevated serum creatinine
concentration (ESCC), 18% nephrotic syndrome (NS), 18% purpura,
Among them, proteinuria did not raise the risk of ESCC, which is
contrary to NS (P < 0.01) or H (P < 0.05). The older the patient, the
more susceptible to ESCC (81% after 60 years, P < 0.01), NS (52/38
years, P < 0.02) or H (48/36 years, P < 0.02). ESCC is less frequent
among patients who have Berger's disease than those with Henoch-
Schönlein purpura or liver disease (13/42 vs. 11/17, P < 0.02). The mean
duration between the first clinical symptoms and the histological
diagnosis is 44.6 months (range: 0.13 to 412.6), 65 months in case of
ESCC, 30 months when the serum creatinine concentration is normal
(this difference is not statistically significant). In conclusion, in these
patients, among the first clinical symptoms, older age, NS or H are risk
factors of ESCC. The last is also more frequent in case of secondary
IgA nephritis.
Clinical trial of a new synthetic polyacrylonitrile membrane (PAN):
First results. V. .Joyeux, B. Coevoet, C. Massart, P. Le Pogamp, andJ.
Brasseur, Nephrology Unit, Enzymoiogy Laboratory, CHRU Rennes,
Nephrology Unit, CH Saint-Quentin, France. A new high flux poly-
acrylonitrile membrane has been developed by ASAHI. Twenty-four
sessions were performed with the PAN capillary, 1.5 m2 area (PAN 15
Dx) device. We determined the clearances for urea, creatinine, phos-
phate and uric acid, during hemodialysis and after 30, 40 and 60
minutes, for 200, 250 and 300 mi/mm blood flows [filtration rate (FR): 13
ml/min]. We calculated extraction coefficients or percent diminution for
these substances and /3-microglobu1in (/32m), and also urea KT/V in
usual treatment conditions (mean blood flow 260 mI/mn; FR 13/mi/mn).
Mean filtration coefficient, calculated every 30 mn for 12 sessions (76
measurements) was 32 mI/hr/mm Hg.
Clearances mi/rn in
(mean UF rate:
13 mI/mm)
Extraction
coefficient
decrease
Blood flow 200 250 300 Mean: 260
mi/mm
Urea 170 203 213 0.73
Creatinine 139 173 178 0.67
Phosphates 141 171 175 0.45
Uric acid 129 157 173 0.71
f32m 0.58
Urea KTN 1.22
For 12 sessions we assessed leukocyte and platelet counts before and
after 15 and 20 mm, and C3a plasma concentrations before and after 5,
10, 14, 60 and 240 mm. The C3a peak after 5 mm remained below 700
ng/ml (initial value, 450 ng/ml).
TO T15 T20
Leucocytes/mm3 6.7 5.6 6
Platelets/mm3 227 215 216
Clinical tolerance of dialysis was good during the 24 sessions (hypoTA:
4%, cramps: 8%) for a weight loss of 4.5% of dry body weight. Blood
recovery was estimated as good in 22/24 sessions (92%). Mean value of
residual blood volume was 0.38 ml (5 measures) for a mean dose of 0.35
U/kg/mm heparin, and a fluid loss of 3 kg.
HTLV-1 antibodies in hemodialyzed (lID) patients. H. Fessi, P.
Dosquet, M.C. Dazza, F. Simon, A. Elias, and J.Ph. Mery, Depart-
ment of Nephrology, Department of Virology and Blood Center,
Hôpital Bichat, Paris, France. Between February 1, 1989 and October
31, 1990, all patients (pts) treated in one Paris chronic HD unit were
prospectively tested for HTLV-l antibodies. Of 71 pts tested (39 males,
32 females—mean age 53,5 16.1 years], 52 were Caucasian, 16 were
Black (8 originating from Africa and 8 from the French West Indies) and
3 were from Asia. Two pts tested positively by ELISA but only 1 was
confirmed by Western Blot. This pt, a 50-year-old, HIV negative, Black
female originated from Guadeloupe and has been on chronic HD since
December 1984. Retrospective analysis of stored serum samples
showed she was HTLV-l positive since beginning dialysis. It was not
possible to conclude whether she was infected via the single transfusion
she received a month before, or earlier by another route either in Paris
or in Guadeloupe. HTLV-1 infection remained until now totally asymp-
tomatic. As in other countries, the prevalence of HTLV-1 antibodies
among our HD pts (1.4%) is much higher than in the general population
(prevalence of 0.011% in continental French blood donors). Therefore,
we think that HD pts should be systematically screened for HTLV-l
antibodies.
